EDSA News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$25.7M

Volume

63.81K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

Acute Respiratory Distress Syndrome Market to Grow Steadily at a 3.8% CAGR Through 2036, Supported by Emerging ARDS Therapies | DelveInsightThe ARDS market is projected to grow at a 3.8% CAGR through 2036, valued at USD 1.7 billion in 2025 across seven major markets. Growth is driven by rising ARDS incidence, advancements in critical care management, and the entry of emerging therapies including MultiStem, ExoFlo, ThyrOxy, and Gelsolin. Currently, no FDA-approved therapies specifically treat ARDS, with mechanical ventilation remaining the standard care approach.GlobeNewswire Inc. · Jun 3, 2026

Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsightOver 18 pharmaceutical companies are developing targeted therapies for vitiligo, with promising pipeline drugs showing potential to transform treatment options beyond conventional approaches like corticosteroids and phototherapy.GlobeNewswire Inc. · Aug 14, 2025

Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan CapitalDr. Pardeep Nijhawan and Velan Capital have updated their beneficial ownership of securities in Edesa Biotech, Inc. Dr. Nijhawan acquired 100 Series B-1 Convertible Preferred Shares, while Velan Capital acquired 568 Series B-1 Convertible Preferred Shares, both for investment purposes.GlobeNewswire Inc. · Feb 13, 2025

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.Dr. Pardeep Nijhawan, the CEO of Edesa Biotech, Inc., has acquired beneficial ownership of more than 2% of the company's common shares through a series of transactions and the granting of restricted share units.GlobeNewswire Inc. · Sep 13, 2024

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketShares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ: ROI) shares rose 84.3% to $0.2678 in pre-market trading after declining 9% on Tuesday. Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 28.6% to $10.93 in pre-market trading. C4 Therapeutics, Inc. (NASDAQ: CCCC) gained 28.6% to $3.01 in pre-market trading after the company announced positive data from CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Stifel upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12. Mynaric AG (NASDAQ: MYNA) shares surged 16.9% to $5.60 in pre-market trading after the company received a $33 million order from Northrop Grumman. MyMD Pharmaceuticals, Inc. (NASDAQ:Benzinga · Dec 13, 2023

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Urban Outfitters reported quarterly earnings of 88 cents per share, topping the analyst consensus estimate of 82 cents per share. The company reported record quarterly sales of $1.28 billion which exceeded analyst expectations of $1.26 billion, according to data from Benzinga Pro. Urban Outfitters shares fell 9.9% to $32.73 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers AgileThought, Inc. (NASDAQ: AGIL) shares jumped 206.4% to $0.2514 after gaining 5% on Tuesday. PaxMedica, Inc. (NASDAQ: PXMD) rose 33% to $1.08 as the company announced pricing of $7 million public offering. SciSparc Ltd. (NASDAQ: SPRC) gained 29.5% to $8.25 after the company announced it signed a non-binding letter of intent to merge with a vehicle importer company in Israel. Agape ATP Corporation (NASDAQ: ATPC) climbed 22% to $1.15. Agape ATP announced a $1 million share repurchase plan over the next 6 months. Ryvyl Inc. (NASDAQ: RVYL) rose 21.6% to $3.77. The company recently posted a narrower loss for the third quarter. Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares rose 19.3% to $0.2340. HeartSciences recently announced closing ...Benzinga · Nov 22, 2023

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionGainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc. Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares climbed 102% to $0.7961 after gaining more than 6% on Thursday. Shift Technologies, Inc. (NASDAQ: SFT) gained 60% to $0.2145, after falling around 21% on Thursday. C3is Inc. (NASDAQ: CISS) gained 32% to $0.5625. Comtech Telecommunications Corp. (NASDAQ: CMTL) shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results. Versus Systems Inc. (NASDAQ: VS) shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday. Outlook Therapeutics, Inc. (NASDAQ: OTLK) gained 26% to $0.3448 SunOpta Inc. (NASDAQ: STKL) gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature's Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results. PSQ Holdings, Inc. (NYSE: PSQH) climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth. EHang Holdings Limited (NASDAQ: EH) jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China. SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia. Celularity Inc. (NASDAQ: CELU) rose 17.7% to $0.3179. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 16% to $0.3826. Hecla Mining Company (NYSE: HL) climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4. Viasat, Inc. (NASDAQ: VSAT) climbed 13.5% to $19.06. Coeur Mining, Inc. (NYSE: CDE) gained 13.2% to $2.5399. Groupon, Inc. (NASDAQ: GRPN) jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target. Synchronoss Technologies, Inc. (NASDAQ: SNCR) surged 13% to $0.5426. Oblong, Inc. (NASDAQ:Benzinga · Oct 13, 2023

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketGainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading. Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares gained 70% to $0.67 in pre-market trading after gaining more than 6% on Thursday. Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 64% to $0.3296 in pre-market trading. Versus Systems Inc. (NASDAQ: VS) shares rose 55.5% to $0.5114 in pre-market trading after jumping more than 52% on Thursday. RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 31.1% to $0.4876 in pre-market trading. RedHill Biopharma recently said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S. Army-funded in vivo Ebola virus study, making it the first host-directed molecule to show activity in the Ebola virus disease.. Datasea Inc. (NASDAQ: DTSS) shares jumped 29.2% to $0.3220 in pre-market trading. Datasea recently said FY23 revenue fell 59% to $7.045 million. Shift Technologies, Inc. (NASDAQ: ...Benzinga · Oct 13, 2023

Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers OpGen, Inc. (NASDAQ: OPGN) jumped 593% to $2.33 following two SEC filings from the precision medicine company. The company has received an advanced payment of €750,000 related to the sale of certain Unyvero A50 systems by Curetis to a strategic partner. OpGen also announced a Preferred Stock Purchase Agreement. It signed an agreement with a certain investor to acquire 1,000 shares priced at $1,000 each, with gross proceeds of $1 million. Secoo Holding Limited (NASDAQ: SECO) shares climbed 577.7% to $2.17 after gaining around 12% on Wednesday. Versus Systems Inc. (NASDAQ: VS) shares jumped 305% to $0.8728 after gaining around 7% on Wednesday. Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 90.1% to $0.4601, after gaining over 3% on Wednesday. Atreca, Inc. (NASDAQ: BCEL) gained 87% to $0.4424. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 56.8% to $0.4235. ReShape Lifesciences was granted U.S. patent #11779482 for "Intragrastric Device for Treating Obesity." BSQUARE Corporation (NASDAQ: BSQR) rose 48.4% to $1.84. Kontron America agreed to acquire BSQUARE for $1.90 per share in an all-cash transaction, representing an implied equity value of $38 million. Edesa Biotech, Inc. (NASDAQ: EDSA) gained 37% to $3.70. Edesa Biotech recently announced a one-for-seven reverse share split. LL Flooring Holdings, Inc. (NYSE: LL) jumped 35% to $3.9800. Live Ventures submitted a proposal to acquire LL Flooring for $5.85 per share in cash. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 28.8% to $8.82. Scholar Rock priced upsized $85 million public offering of 12,408,760 common shares at $6.85 per share. LogicMark, Inc. (NASDAQ: LGMK) jumped 27% to $1.9824. Genetron Holdings Limited (NASDAQ: GTH) gained 26% to $1.1994. Genetron Health entered into definitive merger agreement for going private transaction. Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) jumped 24% to $4.65. The company recently announced the successful completion and early discontinuation of the Ibezapolstat Phase 2b trial for the treatment of C. difficile infection. Blue Star Foods Corp. (NASDAQ: BSFC) gained 23% ...Benzinga · Oct 12, 2023

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Baudax Bio, Inc. (NASDAQ: BXRX) gained 109% to $0.6287 after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors. Chico's FAS, Inc. (NYSE: CHS) shares climbed 61.7% to $7.45 following the announcement of its acquisition by Sycamore Partners for $1 billion. Aditxt, Inc. (NASDAQ: ADTX) gained 57% to $20.47. Axcella Health Inc. (NASDAQ: AXLA) rose 31.3% to $9.08. Inpixon (NASDAQ: INPX) shares gained 23.6% to $0.1729 after gaining around 10% on Wednesday. Soleno Therapeutics, Inc. (NASDAQ: SLNO) jumped 22.2% to $25.25. Soleno Therapeutics reported pricing of approximately $120 million underwritten public offering of common stock and concurrent private placement of common stock and/or pre-funded warrants. Aytu BioPharma, Inc. (NASDAQ: AYTU) gained 22% to $2.33 following fourth-quarter results. Organogenesis Holdings Inc. (NASDAQ: ORGO) gained 20.4% to $3.19. Sarcos Technology and Robotics Corporation (NASDAQ: STRC) gained 20% to $0.80 after the company announced it was awarded a $13.8 million USD contract by the U.S. Air Force for the advancement of its AI and machine learning software. Adamas One Corp. (NASDAQ: JEWL) gained 18% to $0.9200. USA Compression Partners, LP (NYSE: USAC) climbed 14.7% to $25.94. Gritstone bio, Inc. (NASDAQ: GRTS) gained 14.2% to $1.36. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 13.7% to $4.08. Connexa Sports Technologies recently announced that it received a letter from the Nasdaq regarding the late filing of its quarterly report. VinFast Auto Ltd. (NASDAQ: VFS) climbed 13.6% to $12.73 following a report suggesting the company is planning to set up a manufacturing plant in India. Gritstone bio, Inc. (NASDAQ: GRTS) shares rose 13.5% to $1.3550 after the company announced it was awarded a BARDA contract to conduct a Phase 2b comparative study evaluating a next-generation vaccine candidate for COVID-19 valued at ...Benzinga · Sep 28, 2023

EDSAEdesa Biotech, Inc. Common Shares

EDSA

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any EDSA yet.

Related Tickers

Earnings

Volume

63.81K